What is Cliovana?
Cliovana operates at the forefront of reproductive health innovation, offering a patented, non-invasive procedure specifically engineered to enhance female arousal and orgasmic response. By utilizing advanced sound wave technology, the company addresses a critical gap in the clinical sexual health market. Its business model is dual-faceted, targeting both individual consumers seeking improved intimate well-being and medical practitioners—including gynecologists, medical spas, and plastic surgeons—who are looking to diversify their service offerings with evidence-based, high-demand treatments. The company's commitment to research-backed outcomes serves as a cornerstone for its market authority, bridging the divide between elective aesthetic procedures and functional sexual health therapy.
How much funding has Cliovana raised?
Cliovana has raised a total of $20M across 1 funding round:
Other Financing Round
$20M
Other Financing Round (2019): $20M with participation from SCG Partners
Key Investors in Cliovana
SCG Partners
A private equity firm focused on providing strategic capital and operational support to growth-stage companies across various sectors.
What's next for Cliovana?
With this major strategic investment, Cliovana is poised to accelerate its commercial footprint and expand its clinical network. The capital will likely be deployed toward scaling operational infrastructure, enhancing research and development for future iterations of its sound wave technology, and broadening its reach within the medical aesthetics and gynecology markets. As the company transitions into a more mature phase of its lifecycle, the focus will shift toward establishing long-term clinical partnerships and solidifying its brand presence in the global wellness economy. The strategic roadmap suggests a concerted effort to normalize sexual health as a standard component of comprehensive women's healthcare, potentially setting the stage for future market expansion and increased adoption among specialized medical providers.
See full Cliovana company page
